NO20081675L - Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika - Google Patents

Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika

Info

Publication number: NO20081675L
Authority: NO; Norway
Prior art keywords: disorders; benzenesulfonamides; thiadiazol; cyclic; compounds
Prior art date: 2005-10-06

Application number

NO20081675A

Other languages

English (en)

Norwegian (no)

Inventor

Hans Matter

Maike Glien

Karl Schoenafinger

Stefanie Keil

Matthias Urmann

Wolfgang Wendler

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-06

Filing date

2008-04-04

Publication date

2008-04-23

2008-04-04 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2008-04-23 Publication of NO20081675L publication Critical patent/NO20081675L/no

Links

-1 Cyclic N- [1,3,4] -thiadiazol-2-yl-benzenesulfonamides Chemical class 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
108010015181 PPAR delta Proteins 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
208000035475 disorder Diseases 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
206010022489 Insulin Resistance Diseases 0.000 abstract 1
229940122054 Peroxisome proliferator-activated receptor delta agonist Drugs 0.000 abstract 1
229940080774 Peroxisome proliferator-activated receptor gamma agonist Drugs 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
230000003210 demyelinating effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000004129 fatty acid metabolism Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
210000001428 peripheral nervous system Anatomy 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Plural Heterocyclic Compounds (AREA)

NO20081675A 2005-10-06 2008-04-04 Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika NO20081675L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05021785		2005-10-06
PCT/EP2006/009299 WO2007039173A1 (fr)	2005-10-06	2006-09-26	N-[1,3,4]-thiadiazol-2-yl-benzène sulfonamides cycliques, procédés pour leur préparation et leur utilisation en tant que substances pharmaceutiques

Publications (1)

Publication Number	Publication Date
NO20081675L true NO20081675L (no)	2008-04-23

Family

ID=45218083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081675A NO20081675L (no)	2005-10-06	2008-04-04	Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika

Country Status (18)

Country	Link
US (1)	US7683181B2 (fr)
EP (1)	EP1937659B1 (fr)
JP (1)	JP2009510145A (fr)
KR (1)	KR20080050472A (fr)
CN (1)	CN101282952A (fr)
AR (1)	AR056562A1 (fr)
AT (1)	ATE487706T1 (fr)
AU (1)	AU2006299087A1 (fr)
BR (1)	BRPI0616886A2 (fr)
CA (1)	CA2624326A1 (fr)
DE (1)	DE602006018172D1 (fr)
IL (1)	IL190464A0 (fr)
MA (1)	MA29812B1 (fr)
NO (1)	NO20081675L (fr)
NZ (1)	NZ567205A (fr)
RU (1)	RU2008113208A (fr)
UY (1)	UY29847A1 (fr)
WO (1)	WO2007039173A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101815512B (zh)	2007-10-04	2013-04-24	弗·哈夫曼-拉罗切有限公司	环丙基芳基酰胺衍生物和其用途
KR20100101165A (ko)	2007-12-26	2010-09-16	사노피-아벤티스	사이클릭 피리딜ｎ（１,３,４）티아디아졸２일-벤젠 설폰아미드, 이들의 제조방법 및 약제로서의 이들의 용도
EP2428504B1 (fr)	2008-04-14	2017-05-17	The Board of Regents of the University of Texas System	Inhibiteurs de petites molécules du domaine d'homologie de la pleckstrine, et leurs méthodes d'utilisation
CN103096893B (zh) *	2010-06-04	2016-05-04	阿尔巴尼分子研究公司	甘氨酸转运体-1抑制剂、其制备方法及其用途
CA2895162C (fr)	2012-12-14	2021-03-09	D. Lynn Kirkpatrick	Procedes et compositions pour l'inhibition de cnksr1
CA2983260C (fr)	2015-04-20	2024-01-23	Phusis Therapeutics, Inc.	Composes de sulfonamide, compositions et methodes servant a inhiber l'amplificateur de connecteur du suppresseur de kinase de ras-1 (cnksr1)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0110428A (pt) *	2000-04-28	2003-06-17	Sankyo Co	Composto ou um seu sal farmacologicamente aceitável, composição farmacêutica, usos de um composto ou um seu sal farmacologicamente aceitável, de um modulador de ppar gama e de um antagonista parcial, agentes que inibe a diferenciação de adipócitos, que acentua ou recupera a função osteogênica, para tratamento ou prevenção de osteoporose, que tem atividade moduladora de ppar gama, diminuidor do açúcar no sangue, para tratamento ou prevenção de diabetes melito, e, para tratamento ou prevenção

2006
- 2006-09-26 DE DE602006018172T patent/DE602006018172D1/de active Active
- 2006-09-26 BR BRPI0616886-8A patent/BRPI0616886A2/pt not_active IP Right Cessation
- 2006-09-26 WO PCT/EP2006/009299 patent/WO2007039173A1/fr active Application Filing
- 2006-09-26 CA CA002624326A patent/CA2624326A1/fr not_active Abandoned
- 2006-09-26 AU AU2006299087A patent/AU2006299087A1/en not_active Abandoned
- 2006-09-26 JP JP2008533905A patent/JP2009510145A/ja not_active Abandoned
- 2006-09-26 KR KR1020087008276A patent/KR20080050472A/ko not_active Withdrawn
- 2006-09-26 AT AT06805858T patent/ATE487706T1/de not_active IP Right Cessation
- 2006-09-26 EP EP06805858A patent/EP1937659B1/fr active Active
- 2006-09-26 CN CNA2006800370657A patent/CN101282952A/zh active Pending
- 2006-09-26 NZ NZ567205A patent/NZ567205A/en not_active IP Right Cessation
- 2006-09-26 RU RU2008113208/04A patent/RU2008113208A/ru not_active Application Discontinuation
- 2006-10-04 AR ARP060104360A patent/AR056562A1/es unknown
- 2006-10-06 UY UY29847A patent/UY29847A1/es not_active Application Discontinuation
2008
- 2008-03-26 IL IL190464A patent/IL190464A0/en unknown
- 2008-03-31 MA MA30790A patent/MA29812B1/fr unknown
- 2008-04-04 NO NO20081675A patent/NO20081675L/no not_active Application Discontinuation
- 2008-04-04 US US12/062,753 patent/US7683181B2/en active Active

Also Published As

Publication number	Publication date
DE602006018172D1 (de)	2010-12-23
WO2007039173A1 (fr)	2007-04-12
AR056562A1 (es)	2007-10-10
US7683181B2 (en)	2010-03-23
EP1937659A1 (fr)	2008-07-02
RU2008113208A (ru)	2009-10-10
ATE487706T1 (de)	2010-11-15
CA2624326A1 (fr)	2007-04-12
BRPI0616886A2 (pt)	2011-07-05
KR20080050472A (ko)	2008-06-05
UY29847A1 (es)	2007-05-31
AU2006299087A1 (en)	2007-04-12
EP1937659B1 (fr)	2010-11-10
IL190464A0 (en)	2008-11-03
US20080280959A1 (en)	2008-11-13
NZ567205A (en)	2010-05-28
JP2009510145A (ja)	2009-03-12
MA29812B1 (fr)	2008-09-01
CN101282952A (zh)	2008-10-08

Similar Documents

Publication	Publication Date	Title
NO20081367L (no)	2008-06-13	Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika
NO20092293L (no)	2009-09-08	Sulfonyl-fenyl-2H-[1,2,4]oksodiazol-5-onderivater, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytiske midler
MX2010006647A (es)	2010-08-17	Piridil-n-[1,3,4]-tiadiazol-2-il-bencenosulfonamidas ciclicas, procedimientos para su preparacion y su uso como productos farmaceuticos.
NO20081682L (no)	2008-05-06	4-oksy-N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
NO20081369L (no)	2008-05-28	Fenyl- og pyridinyl-1,2,4-oksadiazolonderivater, fremgangsmate for deres fremstilling og deres anvendelse som farmasoytika
NO20064951L (no)	2006-10-30	1,3,4-oksadiazol-2-oner som PPAR delta-modulatorer og deres anvendelse
NO20081681L (no)	2008-04-29	N-[1,3,4]-tiadiazol-2-yl-benzensulfonamider, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
NO20082124L (no)	2008-06-20	Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20071577L (no)	2007-05-02	Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
NO20081675L (no)	2008-04-23	Cykliske N-[1,3,4]-tiadiazol-2-yl-benzensulfonamlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
TNSN06317A1 (en)	2007-12-03	Oxadiazolone derivatives as ppar delta agonists
TW200505880A (en)	2005-02-16	Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
TW200510352A (en)	2005-03-16	Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
NO20081676L (no)	2008-04-29	Bicykliske aryl-sulfonylsyre[1,3,4]-tiadlazol-2-yl-amlder, fremgangsmate for fremstilling derav og deres anvendelse som farmasoytika
NO20063860L (no)	2006-08-29	7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler
NO20081368L (no)	2008-06-18	Derivater av 2-amintiazoler og 2-aminooksazoler, fremgangsmate for fremstilling derav samt deres anvendelse som farmasoytika
TW200505830A (en)	2005-02-16	Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
NO20054381L (no)	2005-09-21	1,3-substituerte sykloalkylderivater med sure, som oftest heterosykliske grupper, deres fremstilling og deres anvendelse som legemiddel
NO20052172D0 (no)	2005-05-03	4-aminopiperidinderivater, fremgangsmate for deres fremstilling og deres anvendelse som medikamenter
MX2007010841A (es)	2007-11-09	8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos.
DE502004006253D1 (de)	2008-04-03	Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung
TW200730516A (en)	2007-08-16	Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
TW200508229A (en)	2005-03-01	Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
ATE440826T1 (de)	2009-09-15	Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen
EA200900312A1 (ru)	2009-06-30	Производные 3,4-дигидробензо[1,2,3]тиадиазин-1,1-диоксида, способ их получения, лекарственные средства, содержащие указанные производные, и их применение

Legal Events

Date	Code	Title	Description
2012-04-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application